Pipeline

We develop in parallel subcutaneous, oral, and transdermal delivery systems.

With multiple delivery methods in development, Starton can expand the number of medicines it is able to deliver continuously, based on patients’ individualized needs and provide multiple avenues for success. 

* other active ingredients are being researched at our facility that have not yet been disclosed

Subcutaneous delivery has broader applicability with multiple ambulatory pumps registered and available in the market and a growing number of on-body injectors. For this reason, Starton began the development of STAR-LLD using an ambulatory pump. This allowed us to get into the clinic sooner. 

Transdermal drug delivery patch is a method of delivering drugs systemically by applying a drug formulation onto intact and healthy skin.